Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.55 |
| ▸ | MME | P08473 | 2/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ACE | P12821 | 1/20 | 0.54 |
| ▸ | CPA1 | P15085 | 1/20 | 0.54 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | FPR2 | P25090 | 6/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7271174 | 1.00 | SIGMAR1 (0.56) | SIGMAR1NAALAD2MMEFOLH1L3MBTL1 | |
| SCHEMBL1958454 | 1.00 | SIGMAR1 (0.56) | SIGMAR1NAALAD2MMEFOLH1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL6953632 | 0.98 | SIGMAR1 (0.55) | SIGMAR1NAALAD2MMEFOLH1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL393424 | 0.98 | SIGMAR1 (0.55) | SIGMAR1NAALAD2MMEFOLH1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL393423 | 0.98 | SIGMAR1 (0.55) | SIGMAR1NAALAD2MMEFOLH1L3MBTL1 | |
| Acetic Acid SCHEMBL28580204 | 0.95 | SIGMAR1 (0.51) | SIGMAR1NAALAD2MMEFOLH1L3MBTL1 | |
| SCHEMBL28888764 | 0.92 | NAALAD2 (0.49) | SIGMAR1NAALAD2MMEFOLH1L3MBTL1 | |
| SCHEMBL25424588 | 0.91 | MME (0.61) | SIGMAR1MMEACECPA1ACE2 | |
| SCHEMBL25424592 | 0.91 | MME (0.61) | SIGMAR1MMEACECPA1ACE2 | |
| Nitric Acid SCHEMBL28598479 | 0.91 | CPA1 (0.49) | SIGMAR1NAALAD2MMEFOLH1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | SOOCHOW UNIVERSITY (CN) | 2025-02-27 | — | — | US | claimed |
| CN-118239879-A | Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine | 泰山学院 | 2024-06-25 | — | — | CN | claimed |
| WO-2024107038-A1 | ETHYL PHENYLALANINE AMIDO COLLAGEN AND COMPOSITION CONTAINING SAME | (주)한국생명과학연구소 | 2024-05-23 | — | — | WO | claimed |
| CN-115710232-A | Compound containing triazolinone structure, preparation method thereof and application of compound as herbicide | 中国农业大学 | 2023-02-24 | — | — | CN | claimed |
| CN-102781236-A | Amino acid conjugates of quetiapine, methods of making and using the same | KEMPHARM INC | 2012-11-14 | — | — | CN | claimed |
| US-12415835-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-16 | — | — | US | disclosed |
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | SOOCHOW UNIVERSITY (CN) | 2025-02-27 | — | — | US | disclosed |
| CN-117924173-B | Aniline quaternary ammonium salt chiral phase transfer catalyst and application thereof in asymmetric alkylation catalysis of amino acid derivatives | 广东工业大学 | 2024-07-09 | — | — | CN | disclosed |
| CN-118239879-A | Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine | 泰山学院 | 2024-06-25 | — | — | CN | disclosed |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-05-23 | — | — | US | disclosed |
| WO-2024107038-A1 | ETHYL PHENYLALANINE AMIDO COLLAGEN AND COMPOSITION CONTAINING SAME | (주)한국생명과학연구소 | 2024-05-23 | — | — | WO | disclosed |
| WO-2024107038-A1 | ETHYL PHENYLALANINE AMIDO COLLAGEN AND COMPOSITION CONTAINING SAME | (주)한국생명과학연구소 | 2024-05-23 | — | — | WO | disclosed |
| EP-0552417-A1 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| EP-0528312-A2 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-02-24 | — | — | EP | disclosed |
| WO-1993000108-A1 | NOVEL INHIBITORS OF PLATELET AGGREGATION | CORVAS INTERNATIONAL, INC. (US) | 1993-01-07 | — | — | WO | disclosed |
| CN-1051555-A | N-(imidazolyl) the alkyl alanine derivatives that replaces | SMITHKLINE BEECHAM CORP (US) | 1991-05-22 | — | — | CN | disclosed |
| EP-0412508-A1 | Analogues of vasopressin, their preparation and pharmaceutical use | CESKOSLOVENSKA AKADEMIE VED (CS) | 1991-02-13 | — | — | EP | disclosed |
| US-4382923-A | Tetrapeptide acylhydrazides, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1983-05-10 | — | — | US | disclosed |
| US-4337247-A | ANALGESICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-06-29 | — | — | US | disclosed |
| EP-0050828-A1 | Tetrapeptide acylhydrazides, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1982-05-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | VIP, NGLY1, GLP1R | SIGMAR1 4682/4885NAALAD2 236/4885MME 404/4885 |
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | CASP4, CASP3, CASP14 | SIGMAR1 1147/4885NAALAD2 3475/4885MME 4862/4885 |
| US-12415835-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | SIGMAR1 4682/4885NAALAD2 236/4885MME 404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.